Skip to main content
TipRanks
Go Ultimate75% OFF

Medrx Co., Ltd. (4586) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Medrx Co., Ltd. has a market cap or net worth of JPY 3.71B. The enterprise value is JPY 2.56B.

Market Cap
JPY 3.71B
Enterprise Value
JPY 2.56B

Share Statistics

Medrx Co., Ltd. has 74,147,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
74,147,100
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Medrx Co., Ltd.’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -45.28%.

Return on Equity (ROE)
-0.46
Return on Assets (ROA)
-0.43
Return on Invested Capital (ROIC)
-45.28%
Return on Capital Employed (ROCE)
-0.45
Revenue Per Employee
6.10M
Profits Per Employee
-44.64M
Employee Count
21
Asset Turnover
0.06
Inventory Turnover
0.89

Valuation Ratios

The current PE Ratio of Medrx Co., Ltd. is -3.58. Medrx Co., Ltd.’s PEG ratio is -0.12.

PE Ratio
-3.58
PS Ratio
187.17
PB Ratio
2.11
Price to FCF
0.00
Price to Operating Cash Flow
0.00
PEG Ratio
-0.12

Income Statement

In the last 12 months, Medrx Co., Ltd. had revenue of 128.08M and earned -937.37M in profits. Earnings per share was -17.44.

Revenue
128.08M
Gross Profit
113.01M
Operating Income
-942.00M
Pretax Income
-925.05M
Net Income
-937.37M
EBITDA
-928.13M
Earnings Per Share (EPS)
-17.44

Cash Flow

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow
0
Free Cash Flow
0
Free Cash Flow per Share
0.00

Dividends & Yields

Medrx Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
0.00%
Earnings Yield
-31.16%

Stock Price Statistics

Beta
1.41
52-Week Price Change
-62.10%
50-Day Moving Average
52.90
200-Day Moving Average
70.97
Relative Strength Index (RSI)
56.83
Average Volume (3m)
1.06M

Important Dates

Medrx Co., Ltd. upcoming earnings date is Feb 05, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 13, 2026
Next Earnings Date
Feb 05, 2027
Ex-Dividend Date
―

Financial Position

Medrx Co., Ltd. as a current ratio of 23.62, with Debt / Equity ratio of 0.00%

Current Ratio
23.62
Quick Ratio
23.40
Debt to Market Cap
0.00
Net Debt to EBITDA
1.89
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Medrx Co., Ltd. has paid 12.32M in taxes.

Income Tax
12.32M
Effective Tax Rate
-0.01

Enterprise Valuation

Medrx Co., Ltd. EV to EBITDA ratio is -1.94, with an EV/FCF ratio of 0.00.

EV to Sales
93.65
EV to EBITDA
-1.94
EV to Free Cash Flow
0.00
EV to Operating Cash Flow
0.00

Balance Sheet

Medrx Co., Ltd. has JPY 1.14B in cash and marketable securities with JPY 0.00 in debt, giving a net cash position of JPY 1.14B billion.

Cash & Marketable Securities
JPY 1.14B
Total Debt
JPY 0.00
Net Cash
JPY 1.14B
Net Cash Per Share
JPY 15.42
Tangible Book Value Per Share
JPY 26.72

Margins

Gross margin is 50.40%, with operating margin of -4852.95%, and net profit margin of -4395.18%.

Gross Margin
50.40%
Operating Margin
-4852.95%
Pretax Margin
-4342.02%
Net Profit Margin
-4395.18%
EBITDA Margin
-4816.85%
EBIT Margin
-4852.95%

Analyst Forecast

The average price target for Medrx Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-81.42%
EPS Growth Forecast
36.56%

Scores

Smart Score
―
AI Score
46